review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1024452751 |
P356 | DOI | 10.1007/S12630-014-0262-2 |
P698 | PubMed publication ID | 25391732 |
P50 | author | James Douketis | Q100404477 |
P2093 | author name string | Benjamin R Bell | |
Pascal E Bastien | |||
Thrombosis Canada | |||
P2860 | cites work | Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632872 |
Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632902 | ||
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 | ||
A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis | Q30441687 | ||
Clinical practice. Heparin-induced thrombocytopenia | Q33372371 | ||
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series | Q33396967 | ||
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial | Q34343613 | ||
Aspirin in patients undergoing noncardiac surgery | Q34412633 | ||
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery | Q34561015 | ||
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial | Q34607209 | ||
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? | Q34714374 | ||
Prevention of venous thromboembolism in obesity | Q35633708 | ||
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752584 | ||
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. | Q37796578 | ||
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). | Q43201516 | ||
Apixaban or enoxaparin for thromboprophylaxis | Q43239246 | ||
Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials | Q43250059 | ||
Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. | Q43847029 | ||
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. | Q43856527 | ||
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery | Q43856529 | ||
New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis | Q44005849 | ||
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison | Q44017888 | ||
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. | Q44017891 | ||
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement | Q44630656 | ||
Rivaroxaban for thromboprophylaxis | Q46246369 | ||
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial | Q47231387 | ||
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. | Q53229008 | ||
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. | Q55044458 | ||
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. | Q55044630 | ||
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial | Q57943255 | ||
P433 | issue | 2 | |
P921 | main subject | venous thromboembolism | Q9397786 |
P304 | page(s) | 194-202 | |
P577 | publication date | 2014-11-13 | |
P1433 | published in | Canadian Journal of Anaesthesia | Q2511577 |
P1476 | title | Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review | |
P478 | volume | 62 |